Showing 8251-8260 of 20875 results for "".
What is the Safety of Statins in Patients with Diabetes?
https://reachmd.com/programs/lipid-luminations/what-is-the-safety-of-statins-in-patients-with-diabetes/6967/At the most recent National Lipid Association (NLA) meeting, host Dr. Alan Brown welcomes Kevin Maki, PhD, FNLA, CLS, Chief Science Officer for Midwest Center for Metabolic and Cardiovascular Research and Adjunct Faculty position in Biostatistics and Applied Epidemiology at DePaul University, ChicagUpdated AACE Guidance on Managing Dyslipidemia in T2D
https://reachmd.com/programs/heart-matters/aace-guideline-updates-dyslipidemia-t2d/54149/Dyslipidemia is a major driver of cardiovascular risk in patients with type 2 diabetes (T2D), and lipid management is a key component of the 2026 AACE diabetes algorithm. Join Dr. Scott Isaacs as he reviews new recommendations on LDL-C goals and individualized care in this population. Dr. Isaacs isVNS Therapy Achieves Cost Neutrality Within 2 Years Across All US Payer Types
https://reachmd.com/programs/practical-neurology/vns-therapy-achieves-cost-neutrality-within-2-years-across-all-us-payer-types/49194/Update on Diabetic Gastroparesis
https://reachmd.com/programs/clinicians-roundtable/update-on-diabetic-gastroparesis/1870/Dr. William Chey reviews newer thinking on the pathophysiology and treatment of this difficult disorder.Breaking Down the Bionic Pancreas: A Device for Dosing Decisions for T1D
https://reachmd.com/programs/diabetes-discourse/breaking-down-the-bionic-pancreas-a-device-for-dosing-decisions-for-t1d/14229/Can the bionic pancreas measure carbs, monitor blood sugar levels, and lower A1c for patients with type 1 diabetes? Find out.A New Lens on DKA: Leveraging the Latest Tech for Improved Patient Outcomes
https://reachmd.com/programs/cme/dka-latest-tech-improved-patient-outcomes/50983/Editor’s note: Since the recording of this activity, the first dual glucose-ketone sensor has been FDA approved in the US. Ketone monitoring is a cornerstone of diabetes management for preventing diabetic ketoacidosis (DKA), yet existing monitoring methods remain suboptimal and are used infrequentlToward Precision Medicine for Genetic Epilepsies: Glucose Transporter Type 1 Deficiency Syndrome
https://reachmd.com/diseases-diagnoses/epilepsy-seizures/toward-precision-medicine-for-genetic-epilepsies-glucose-transporter-type-1-deficiency-syndrome/32055/As we begin to understand the mechanisms of specific genetic epilepsies, tailored treatments have the potential to be transformative, as in GLUT1-DS.Exploring IGF1R as a New Therapeutic Target in Myasthenia Gravis
https://reachmd.com/programs/neurofrontiers/exploring-igf1r-as-a-new-therapeutic-target-in-myasthenia-gravis/35491/A recent study explored the potential roles of uric acid and the type 1 insulin-like growth factor receptor in the development and progression of myasthenia gravis (MG). Read about the findings and their implications for MG care.Sports related brain injuries
https://reachmd.com/programs/clinicians-roundtable/sports-related-brain-injuries/7/Pulmonologist, Dr. Ankin, discusses the types and prevalence of sports related brain injuries and sleep disorder breathing.Investigating T2 Inflammation in Severe Asthma & COPD
https://reachmd.com/programs/deep-breaths-updates-chest/investigating-t2-inflammation-in-severe-asthma-copd/13424/Find out how to identify type 2 inflammation in patients with severe asthma and COPD.